Wedbush Boosts Lexicon Pharmaceuticals, Inc. (LXRX) Price Target to $38.00


The brokerage currently has an outperform rating on the biopharmaceutical company's stock. A number of other research firms also recently weighed in on LXRX.



from Biotech News